adectopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.adectopharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Adecto
Description Dedicated to a cancer free Adecto Pharmaceuticals is an early-stage therapeutic company developing a treatment against ADAM8-positive
Keywords N/A
Server Information
WebSite adectopharma faviconadectopharma.com
Host IP 185.230.63.186
Location -
Related Websites
Site Rank
More to Explore
adectopharma.com Valuation
US$1,562,762
Last updated: 2023-05-18 07:43:23

adectopharma.com has Semrush global rank of 6,772,822. adectopharma.com has an estimated worth of US$ 1,562,762, based on its estimated Ads revenue. adectopharma.com receives approximately 180,319 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, adectopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,562,762
Daily Ads Revenue US$1,443
Monthly Ads Revenue US$43,277
Yearly Ads Revenue US$519,318
Daily Unique Visitors 12,022
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
adectopharma.com. A 3600 IP: 185.230.63.186
adectopharma.com. A 3600 IP: 185.230.63.171
adectopharma.com. A 3600 IP: 185.230.63.107
adectopharma.com. NS 86400 NS Record: ns8.wixdns.net.
adectopharma.com. NS 86400 NS Record: ns9.wixdns.net.
adectopharma.com. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
adectopharma.com. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
adectopharma.com. MX 3600 MX Record: 10 aspmx2.googlemail.com.
adectopharma.com. MX 3600 MX Record: 10 aspmx3.googlemail.com.
adectopharma.com. MX 3600 MX Record: 1 aspmx.l.google.com.
adectopharma.com. TXT 3600 TXT Record: MS=ms24327935
HtmlToTextCheckTime:2023-05-18 07:43:23
top of page About Adecto Team Technology News Publications Investors & Partners Resources Contact Us Dedicated to a cancer free future About Adecto Adecto Pharmaceuticals is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against aggressive ADAM8-positive cancers and a companion diagnostic to identify patients who can benefit from it. It is the culmination of over 30 years of research hunting down molecules that can be safely targeted to stop both primary cancer growth and metastases. Our mission is to help patients live longer, healthy lives . The ADAM8 protein is expressed on the cancer cell surface, downstream of the NF-κB family of transcription factors known to promote tumor growth, resistance to chemotherapy and metastasis. Consistently, ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, stomach, colon, lungs, liver and pancreas, and is associated with poor patient survival.
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 28 May 2022 08:38:18 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.adectopharma.com/
strict-transport-security: max-age=3600
Age: 66845
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: yKskFaTI/RmB0yGOaMOo6Q==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgd3Bvun3UZxiffLTSLc+G+,m0j2EEknGIVUW/liY8BLLtxbqKixcgheJzihIl22fmTJftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRaluXcXLqQsLyNTbFflh2Ox3yoq2xllFz2x/gYVxnC+jutETI0pKf1HjO7cqAevvP+Mg==,2UNV7KOq4oGjA5+PKsX47FWQphhqZlrQzn660S24P+W8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1653727098.708456333869923844
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 28 May 2022 08:38:19 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1653727098.91556798392532637
content-language: en
strict-transport-security: max-age=3600
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1; Max-Age=20; Expires=Sat, 28 May 2022 08:38:39 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMeL5FEaRcxHGWcbmRLoq7Uw,qquldgcFrj2n046g4RNSVBKUaXHrucSLmP/C0nqrtU9YgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalr38gX67K2PQEyiic6HTDow8hagKs0yRcxnUEM3xk0EQ3QpI/ucnHvfrUjeESIoVekjHtR61h35StOJY7zqfuYc=,2UNV7KOq4oGjA5+PKsX47IVh8rwr1kfSZp8MOIif7faa46R9xNIlpQ4eUPYpBuqs,7npGRUZHWOtWoP0Si3wDp7Nk23bew5jhhUsb0LqPOFk=,wjXkXN74v+Dcwxj+UalvvnvPGFkC+5pK9koG9LmrW4O8MDcmO6GrH5G49pThCUHFmuOkfcTSJaUOHlD2KQbqrA==,xTu8fpDe3EKPsMR1jrheEOzQ1Yui4Wu0SuzxZzs6IE4=,LoUK8/saGAmOxZWtpubo2trAHdy0FKANPjM8fZZ5pn3apGAWEu+gN/ixK0gC05t3mZcbmXPcv3uGIgoY3h/seg==,xTu8fpDe3EKPsMR1jrheENMEqP75Ixuymjkwzabulhc=,xTu8fpDe3EKPsMR1jrheEG18FPUFxQJ/fO53FWfbvL0=,/a5ccLSK1HEmwPNg/x6Oukj9PRT88mBdMS0Gi1BC0nh7YddV8c9vDn2RrrN7UwjQZgrp1cDVb1euATvQU4P9MQ==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
x-wix-google-ccm: 1
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
adectopharma.com Whois Information
Domain Name: ADECTOPHARMA.COM
Registry Domain ID: 1879608836_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enomdomains.com
Updated Date: 2021-10-03T01:55:25Z
Creation Date: 2014-10-09T17:36:25Z
Registry Expiry Date: 2022-10-09T17:36:25Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS8.WIXDNS.NET
Name Server: NS9.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-28T11:18:32Z <<<

Copyright © 2022 WebZZ.US 0.0223